Molecular cloning of gp42, a cell-surface molecule that is selectively induced on rat natural killer cells by interleukin 2: glycolipid membrane anchoring and capacity for transmembrane signaling by unknown
Molecular Cloning of gp42, A Cell-Surface Molecule
That Is Selectively Induced on Rat Natural Killer Cells
by Interleukin 2: Glycolipid Membrane Anchoring
and Capacity for Transmembrane Signaling
By William E . Seaman, Erene C. Niemi, Martha R. Stark,
Robert D. Goldfien, Allan S. Pollock, and John B. Imboden
From the Arthritis/Immunology Section, and the Nephrology Section, Veterans Administration
Medical Center and University of California, San Francisco, California 94121
Summary
We have previously shown that in vitroculture ofrat natural killer (NK) cells in high concentrations
of recombinant interleukin 2 (rIJr2) leads to the expression ofa surface glycoprotein with a molecular
mass of -42 kD. This glycoprotein, gp42, is not induced on other lymphocytes and thus provides
a lineage-specific marker for rIlr2-activated NK cells. We here present the nucleotide sequence
for gp42 cDNA. The open reading frame encodes 233 amino acids with three potential sites
for Winked glycosylation. The deduced amino acid sequence lacks an apparent transmembrane
domain and instead contains a hydrophobic COOH terminus that is characteristic of glycosyl-
phosphatidylinositol (GPI)-anchored surface proteins. Consistent with this, gp42 is cleaved from
the NK-like cell line, RNK-16, by phosphatidylinositol-specific phospholipase C (PI-PLC), as
is gp42 expressed on CHO cells that havebeen transformed with gp42 cDNA. On rIlr2-activated
NK cells, gp42 is resistant to PI-PLC, though our studies suggest that gp42 on these cells is
still expressed as a GPI-anchored molecule.
Antibody to gp42 stimulates in RNK16 cells an increase in inositol phosphates and in intracellular
calcium, signals that are associated with the activation of lymphocytes, including NK cells.
rllr2-activated NK cells, however, lack this response to gp42 as well as to other stimuli. Thus,
gp42, the only NKspecific activation antigen, is a GPI-anchored surface molecule with the capacity
to stimulate transmembrane signaling.
N
atural killer (NK) cells are large granular lymphocytes
that spontaneously lyse certain tumor cells and cell lines
(1-3) . NK cells express relativelyhigh levels of the p75 com-
ponent of the 11,2 receptor (4), and they readily respond to
IL2, as assessed by proliferation (5), by an increase in cyto-
toxicity (5, 6), by increased production of serine proteases
(7), and by a rapid increase in the transcription and transla-
tion ofgenes for at least several important cytokines, including
IFN-y, TNF, and granulocyte/macrophage (GM)'-CSF (5,
8-10).
The IL-2-induced differentiation of NK cells is associated
with the expression of several cell-surface molecules that are
also expressed by activated T lymphocytes, such as the p55
subunit of the IL2 receptor (CD25, reference 11) and CD69
(Leu-23, reference 12). Recently, we described a rat cell sur-
face glycoprotein that is not detectable on freshly prepared
lymphocytes, including NK cells, but that is selectively ex-
'Abbreviations used in this paper. CHO, Chinese hamster ovary; GM,
granulocyte/macrophage; GPI, glycosyl-phosphatidylinositol; InsPs, inositol
phosphates; PI-PLC, phosphatidylinositol-specific phospholipase C.
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pressed on NK cells when they are cultured in high concen-
trations ofrIIL2 (13). The molecule, gp42, is expressed within
6-8 d on all rIL2-activated NK cells. It is also present on
the rat NK-like leukemia cell line, RNK-16, where it was
originally identified (13). It is not, however, induced on T
cells by either M or mitogens. Thus, gp42 appears to be
an activation molecule that is selectively expressed by the NK
cell lineage.
We have isolated cDNAs for gp42 from rIL2-activated
rat NK cells and here present the nucleotide sequence and
the deduced amino acid sequence. Neither sequence shows
significant homology with known proteins. Interestingly, the
sequence contains no putative transmembrane domain and
instead has features characteristic ofproteins attached to the
cell surface membrane by a glycosyl-phosphatidylinositol (GPI)
anchor (14, 15). Several other GPI-anchored proteins on lym-
phocytes can stimulate the intracellular release ofinositol phos-
phates (InsPs) and a rise in intracellular free calcium ([Cal +]),
signals that are associated with lymphocyte activation. We
find that these signals are also generated within RNK-16 cells
by mAbs to gp42.
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Antibodies.
￿
The mAbs against gp42 have been described (13).
Except wherenoted, theanti-gp42 mAbused in these studieswas
from hybridoma 3G7(mouse IgG2a). mAbs OX-18 (anti-rat class
I MHC antigen; reference16), OX-34anti-rat CD2;reference 17),
and OX-45 (a GPI-anchored surfaceprotein on rat leukocytes; ref-
erence 18) were kindly provided by Dr. Alan Williams, Oxford
University, Oxford, UK. For fluorescent staining, mAbs were ei-
ther directly conjugated with fluorescein by published methods
(19, 20) or were identified by a second-step antibody (fluorescein-
conjugated goat anti-mouse Ig;Cappel Laboratories, Malvern, PA).
Studies involving the cross-linking of mouse mAbs used affinity-
purified goat anti-mouse Ig (Cappel Laboratories).
Cells and Cell Culture.
￿
RNK-16 cells were adapted for in vitro
growth as previously described(20) andwere carriedin RPMI 1640
(without 11,2) + 10% FCS, L-glutamine (0.3 mg/ml), penicillin-
K (100 U/ml), and streptomycin sulfate (0.1 mg/ml). rILr2-acti-
vated NK cells were generated by a modification of the method
of Vujanovicet al. (21). Briefly, cells were incubatedin RPMI 1640,
supplemented with 10% FCS, 2 mM glutamine, 5 x 10-5 M
2-ME, streptomycin,penicillin, and 1,000U/ml rIL,2(Cetus Corp.,
Emeryville, CA). After72 h, thenonadherent cellswere discarded,
freshmedium wasadded(including rID2), andincubation wascon-
tinued for another 72 h. Thecells were harvestedby the addition
of PBS containing 0.5 mM EDTA. Chinese hamsterovary (CHO)
cells were carriedin Hams F12medium,supplemented as forRPMI
1640. After transformation, the cells were carried in the same
medium without hypoxanthine (using dialyzed FCS).
Molecular Cloning ofgp42cDNA.
￿
Totalcellular RNAwaspre-
pared from 5 x 108 rat rIL.2-activated NK cells by the guanidine
isothiocyanate method (22). From this, poly(A)' RNA was iso-
latedby absorption on oligo-dT-cellulose beads andused to generate
acDNA libraryby themethod of Gubler andHoffman(23). After
methylation of internal EcoRI sites, EcoRI linkers were attached
and the library was ligated into Agt11 arms (Amersham Corp.,
Arlington Heights, IL). Initial cloning efficiency was 3 x 106
PFU/hg cDNA. 3 x 105 PFU were plated on Y1090 cells, and
expression wasinducedwith IPTGimpregnatednitrocellulose filters.
The denatured filters were screened with a combination of two
anti-gp42mAbs,3G7and6138 (13). In brief, the filterswere washed
in distilledwater and then incubatedfor2 h at room temperature
in PBS containing powdered milk (1 g/100 ml). The filters were
incubated overnight at 4°C with the gp42 mAbs at a concentra-
tion of 10 ug/mleach in PBS/powdered milk. The filterswere then
washed twicein PBScontaining TWEEN-20 (0.05g/100ml). For
detectionof boundmAbs, thefilters were incubated for2 h at 4°C
with affinity-purifiedgoat antibody to mouse Ig that hadbeen con-
jugated to alkaline phosphatase (Calbiochem-Behring Corp., San
Diego, CA), at a final concentration 10 ttg/ml in PBS. The filters
were washed twice in PBS/TWEEN as before and then exposed
to nitroblue tetrazolium chloride (0.34 mg/ml) and 5-bromo-4-
chloro-3-indolylphosphate-p-toluidine salt (0.165 mg/ml) for30 min
in thedark at room temperature in 0.1 MTris.HCI (pH9.5), 0.1 M
NaCl, 50 mM MgCIZ (Protoblot- buffer, PromegaBiotec, Madison,
WI). Thefilterswere rinsedin waterbefore examination forstained
colonies.
Of 36 clones identified, 11 were selected for subdoning, and
7 of these remained positive through three rounds of subdoning.
The phage were partially purified by immunoabsorption using
Lambdasorb° (Promega Biotec), according to the method of the
manufacturer, before the preparation of phage DNA (24). The
purified phage DNAwas then used as asubstrateforamplification
of thecDNA by thePCR(25). Theprimerswere oligonucleotides
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corresponding to flanking sequences in the Xgt11 lacZ gene. The
oligonucleotides were prepared with flanking C1aI sites, providing
an option for releasing the intact insert if the cDNAs contained
internal EcoRl. The amplified product thus included both the
cDNA and adjacent sequences from the lacZ gene, assuring that
the amplified sequences represented the inserted cDNA. For
amplification, 10 ng of substratephage DNA was exposed to 25
pM of each primer and 1.0 U Thermus aquaticus (Taq) DNA poly-
merase (Perkin-Elmer/Cetus Corp., Emeryville, CA) for 25 cycles
in a volume of 50 pl buffer (67 mM Tris-HCI, 6.7 mM MgCl2,
16.6 mM [NH412S04, 1.6 mM dNTPs, 170 Fog/ml BSA), mixed
with 5 p,l DMSO. The cycles included 1.5 min denaturation at
95°C, 1 min annealing at 45 °C, and 2 min enzymaticprimer ex-
tension at 72°C.
Northern Blotting.
￿
Northern blotting utilized amountsof total
cellular RNA or of poly(A)' RNA as indicated. To further as-
sure equal loading with RNA, the replicate samples were loaded
on thesame gel, and onewas examined by staining with ethidium
bromide. The other was transferred to nitrocellulose membranes
(0.45 um; BioRad Laboratories, Richmond, CA). The RNA
containing gels were washed twice in 10x SSC for 20 min per
wash. Nitrocellulose filters were soaked in 20x SSC, andthe RNA
wastransferred overnightusinga20x SSCbath.Filters were baked
at 80°C for 2 h and then incubated (65°C for 20-30 min, then
45'C for 3 h) in hybridization buffer (50% vol/vol formamide,
5x SSC, 0.5% wt/vol SDS, 1x Denhardt's solution, and100pg/ml
salmon sperm DNA). The3'P-labeled probe (1-3 x 107cpm) was
addedin avolume of 10,ulandhybridized overnight at 42°C. The
filters were washed twicefor 15 min at 42'C in 1x SSC + 0.1%
SDS, then twicefor 15 min at 42°C in 0.25x SSC + 0.1% SDS,
before exposure to radiographic film.
Sequencing.
￿
Forfurtheranalysis, includingsequencing, theclones
were ligated in both orientations into the phagemid, Bluescript
SK-2 (Stratagene, San Diego, CA). For sequencing, ssDNA from
two independently derived clones was prepared from transformed
bacteria by rescue with R408 helper phage, accordingto themethod
of the supplier (Stratagene). Sequencing ofboth strands was initi-
ated by using the Sequenasevariant of T7 DNApolymerase (US.
Biochemical Corp., Cleveland, OH) for dideoxy (chain termina-
tion) sequencing (26). Newoligomers, a total of 15, were synthe-
sized as needed to prime overlapping sequences.
The nucleotide sequence of gp42 was compared with sequences
in GenBank (release 61,recheckedon release 64).Thededucedamino
acid sequence wascompared with sequences in Swiss-Prot (release
11) and with deduced amino acid sequences obtained by transla-
tion of part of the GenBank database. Searches were performed
by using the FASTDB program (Intelligenetics, Inc., Mountain
View, CA) on a Sun Workstation. Amino acid domain searches
were performedwith aunitary matrix, a k-tuple of 2, and aword
length of 32. Additional alignments were analyzed with the PEP
program (Intelligenetics, Inc.).
Transformation of CHO Cells.
￿
For transformation of CHO
(dhfr - ) cells, cDNA from one clone (clone 2 in Fig. 2) was sub-
cloned into the vector pXM (27). The cells were transformed by
electroporation, using 101 cells in 1 ml phosphate-buffered sucrose
(9 gm/100 ml) containing 10 Ftg of vector, using a field strength
of either 300 V or 330 W0.4 cm with a25 p.Farad capacitor. The
vector pXM contains the gene for dihydrofolate reductase (dhfr),
permitting selection in the absence of hypoxanthine.
Treatment ofCells with PI-specific Phospholipase C (PI-PLC).
￿
To
cleave surface proteins attached by a GPI-anchor (14, 15), 107 cells
were incubated for 1 h at 37°C in i ml PBS + BSA (1 Fog/100
ml) containing 0.5 U of PI-PLC from Bacillus thuringiewis (ICNKBK Laboratories Inc., Plainview, NY). Cells were subsequently
stained for the expression of gp42 or OX-45. By these methods,
the concentration of PI-PLC used provided maximum release of
gp42 from RNK-16 cells .
Measurement ofInsPs.
￿
InsPs were resolved and quantified as we
have described (20), by labeling cells with ['H]inositol (20-40
fiCi/ml) for 3 h, before stimulation by mAbs. At intervals after
stimulation, aliquots of cells (2-5 x 106) were rapidly pelleted
then lysed in cold 10%TCA. Afterremoval of insoluble material,
the supernatant was extensively extracted with diethyl ether. La-
beled InsPs were resolved by sequential elution using anion-exchange
chromatography with Dowex-1X8 (100-200 mesh) in the formate
form, as described (20) . Alternatively (as indicated) total Insps were
co-eluted in 6 ml of 2M ammonium formate, 0.1M formic acid .
Measurement of[Cal+];.
￿
(Cal' )i was quantified by monitoring
fluorescence ofcells loaded with the calcium-sensitive fluor, indo-1,
as we have described (20) .
Surface Labeling Immunopreciphation, and SDS-PAGE.
￿
These
were performed as we have described (13) .
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Results
Identification and Characterization of the cDNA for gp42.
Seven cDNA clones were isolated by screening a Xgt11 li-
brary prepared from rIIr2-activated NK cellmRNA. Ofthese,
five clones were similar in size (ti1.2 kb) and gave identical
patterns on gel electrophoresis after digestion with Mbol .
Initial evidence that these clones representedgp42 came from
Northern blot analysis using one of the clones : no message
couldbe detected in freshly prepared spleen cells, but a single
message, -1.4 kb, was expressed at high levels in rIL2-
activated NK cells (Fig. 1) . Message was also absent from
whole cellRNA prepared from heart, kidney, or liver (not
shown) .
The cDNA from two independently derived clones was
sequenced . Both strands from one clone were sequenced in
their entirety. For the other, one strand was sequenced in
its entirety, and the second strand was sequenced in portions
Figure 1 .
￿
ThecDNA for gp42 identifies message that
is expressed in rllr2-activatedNK cellsbut not in freshly
prepared spleen cells . Northern blots were probed with
32P-labeledcDNA from clone 2 (A) or, as a control, with
cDNA for glyceraldehyde-3-phosphate dehydrogenase
(GAPDH, reference 60) (B). (Lane 1) poly(A)*RNAfrom
fresh spleen cells, 1 Rg . (Lane 2) Whole cell RNA from
fresh spleen cells, 10 ug. (Lane 3) Whole cell RNA
from rllr2-activated NK cells, 10 kg. The blot was first
probed with cDNA for gp42 and then stripped before
reprobing with GAPDH . Successful removal of the first
probewas documented by exposure to film for 48h, while
the probed blots were exposed only overnight. Message
for gp42 is not detectable in fresh spleen cells but is >100-
fold above background in rIL2-activated NK cells (A,
lane 3) . Message for GAPDH was also increased in HI,
2-activatedNKcellscompared with fresh spleen cells, but
the difference was less than eightfold (B) .that were disparate between the two clones. The two clones
contain an open reading frame with a deduced amino acid
sequence of 233 residues (Fig. 2). The nucleotide sequences
in the open reading frame are identical for the two clones,
with the exception of a single nucleotide at position 708 .
This predicts a conservative change in the deduced amino
acid sequence at position 214 (Met for Val). There are six
additional nucleic acid differences between the two clones
in the 3' untranslated region. The differences could represent
allelic products or mutations that arose during amplification
ofthe cDNA. The two clones also differ in the site of attach-
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Figure 2.
￿
The nucleotide sequence
ofcDNAs for gp42 prepared from two
independently derived clones. The se-
quence for clone 1 is given, together
with the deduced amino acid sequence
in the open reading frame. For clone
2, regions of nucleotide identity are in-
dicated by a dashed line. The solid line
overhead indicates the signal sequence,
as defined by the criteria of von Heijne
(29). Sites for Winked glycosylation
are bracketed. Cysteine residues are in
boldface.
ment of the poly(A) tail, which begins 22 nucleotides from
the AATAAA signal in clone 1 vs. 15 (or 16) nucleotides in
clone 2 (Fig. 2).
Transformation ofCHO cells with clone 21ed to high levels
of expression of gp42, as detected by fluorescent staining with
mAb 3G7 (see Fig. 4 $) . This evidence that the clones con-
tained a full-length open reading frame encoding gp42 was
supported by the following: First, the translational start site
is precededby the nucleotide triplet ACC, in partial fulfillment
of Kozak's criteria (28). Second, in the deduced amino acid
sequence, the first 16 residues form a signal sequence, according
MetIeuI,euTrp 4
Clone 1 GG TTTTCTCTCCCCAGCTTCATCTCTGCCTACTGTCTGACCTGCTCT TGCTGCTCTGG 77
Clone 2 --------------------------------
MetValLouLsuIauCyoValSerMetThrGluklaGlnGluLeuPh&GlnAspProValLouSerArgLetgz 30
Clone 1 ATGGTTCTAGTGCTCTGTGTTTCCATGACTGAAGCCCAAGAGTTGTTccAGGATCCTGTGCTGAGTCGTCTCAACTCT 155
Clone 2 ------------------------------------------------------------------------------
ijiGluThrSerAspLsuLeuLeuLyaCyaThrThrLyoVaLAspProAsnLysProAlaSerGluLeuPheTyrSer 56
Clone 1 TCAGAGAMTCAGATCTGCTCCTGAAGTGTACX40CAAGMGGhCCCCAACAAGCCAGCTICTGAGMCTTTTACTCr 233
Clone 2 ------------------------------------------------------------------------------
PheTyrLysAapAsnHisIleIl*G1 nAr Se isAsnProIeuPhePheIleSerGluAlaAanGluGluAsn 82
Clone 1 TTCTACAAGGACAACCACATCA~CACAACCCACTATTTTTCATCTCAGAAGCCAATGAGGAAAAC 311
Clone 2 ------------------------------------------------------------------------------
SerGlyLeuTyrGlnCyvValValAspAlaLysAspGlyThrIleGlnLysLysSerAepTyrLsuAspIleAspLeu 108
Clone 1 TC'1GGG=ACCAGTGTGrCGTGGACGCTAAGGATGGCACAATTCAGAAAAAGAGrGACTATCTGGATATCGACCTC 389
Clone 2 ------------------------------------------------------------------------------
CysThrSerValSerGlnProValIsuThrLeuGlnHiaGluAlaThrAenLeuklaGluGlyAspLy3ValLyaPhe 134
Clone 1 TGCACTTCTGTATCCCAACCTGTGCTGACTCTGCAACACGAAGCCACTAACCTTGCTGAAGGAGACAAAGTGAAGTTT 467
Clone 2 ------------------------------------------------------------------------------
LeuCyaGluThrGlnLeuGlySerLeuProIleLeuTyrSerPheTyrMetAspGlyGluIleLeuGlyGluProLeu 160
Clone 1 CTTTGTGAGACCCAGCTGGGCTCCCTTCCTATCCTTTACTCATTCTATATGGATGGAGAGATCCTAGGGGAACCTCTG 545
Clone 2 ------------------------------------------------------------------------------
AlaProSerGlyArgAlaAlaSerLeuLeuIleSerValLysAlaGluTrpSerGlyLy an rSe sGlnAla 186
Clone 1 GCTCCCTCTGGCAGAGCTGCCTCCCTCCTCATCTCAGTGAAGGCAGAGTGGAGTGGCAAGAACTACTCCTGTCAAGCT 623
clone 2 ------------------------------------------------------------------------------
G1uAsnLysValSerArgAapIleSerGluProLysLy3PheProLeuValValSerGlyThrAlaSerMetLysSer 212
Clone 1 GAAAACAAAGTCTCCAGAGATATAAGTGAGCCCAAGAAGTTCCCCTTGGTTGTCTCAGGTACTGCCTCAATGAAGAGC 101
Clone 2 ------------------------------------------------------------------------------
233
ThrThrValValIleTrpLeuProValSerCyaLeuValGlyTrpProTrpLeuLeuArgPheSTP
Clone 1 ACCACGGTGGrTATCTGGCTACCTGTAAGCTGCTTGGTGGGATGGCCATGGCTGCTGCGGTTCTGATTTAGTrCTTCA 779
Clone 2 -__-__A__-__-_____--_-_--__-______-___-___-___-________________---_________-__
Clone 1 AGCCCTGCAAAAAAAAAACATGGTATGAAAATAAGAGGCTGCTTATCACAGCAGGTGATTGTGATTT000GTCTGCAC 857
Clone 2 ------------------------------------------------------------------------------
Clone 1 TAGCAAGGACATGATTTTTGCCAATTGTAGATAATCTAATCrAGGGGACrCTGGAGAGGGTATGAATGACAGAGCCTA 935
Clone 2 __________________--____________________T_________-__________-______________--
Clone 1 GAGAGGGATrAGGGGCGCTATGGAGAAGGATGCTGCTGCTGCTGCTGGTCTTCTTGCTCCTGGTGGCrGTTGrTAAGG 1013
Clone 2 -_____________________A___-______--____________________________________--___--
Clone 1 ATTGTCATGTGGTCGTGrTCAAGAGAAGAAGTCGGAGGCATGACTATGAAGATTGGACTTGCTTCAAGGAACCCAATG 1091
Clone 2 _______________-__________-______--__A______________________________-______---
Clone 1 CCCCAAATCAGCAGAAAGTAGTACAAAAAAGGTCTATGCCCCACTTTCCCCTCTAGCCTTCTTTCTCTCCTAACTAGT 1169
Clone 2 __________________C___-T__-___-_C___________ .__________________________________
Clone 1 GTTTGTGAGTTGGAATTGGGGTGGAAAAGGGTTTGGAGGGGAGGCGGAGTTATAAGAACCTAATAAAGTAGCTTTCAA 1247
Clone 2 ------------------------------------------------------------------------------
Clone 1 AATATCTCAGAIUIAAAAAAA 1267
Clone 2 GATAAAAAAAAAAAmino Acid Position
Figure 3.
￿
Hydrophilicity plot of the deduced amino acid sequence for
gp42, demonstrating the hydrophobic signal sequence at amino acid posi-
tions 1-16, and the COON-terminal hydrophobic region.
to the criteria of von Heijne (29) (Fig. 2, dark line). Third,
the predicted molecular mass ofthe protein (26 W) is similar
to the observed molecular mass of deglycosylated gp42 (28
kD), and there are three potential sites for N-linked glyco-
sylation (Asn-XThr/Ser; Fig. 2, bracketed). Further confirma-
tion of the identity of the cDNA came from studies of the
properties of gp42, as discussed below.
The DeducedAmino AcidSequenceforgp42 Predicts a Unique
Protein that Is Attached to the Cell Membrane by a GPI An-
chor. A search for homologies between the nucleotide se-
quence for gp42 and other vertebrate proteins was sought
by a computer search of GenBank. No significant homolo-
gies were found; nucleotide homologies occurred with a
normal distribution and did not extend beyond 3.6 SD in
significance. Likewise, the deduced amino acid sequence for
gp42 lacked extensive homology to any amino acid sequences
in Swiss-Prot; the frequency ofhomologies followed a normal
distribution and in only one instance did homology extend
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FLUORESCENCE (log scale)
to five consecutive amino acids. In addition, the deduced amino
acid sequence of gp42 was compared with all deduced se-
quences from GenBank. Again, no extensive homologies were
found, but the highest match was of interest in that it was
to the human high affinity Fc receptor, FcRI (CD64, refer-
ence 30), amino acid residues 172-374 (27% residue iden-
tity, significance 7.19 standard deviations above the mean score
of4,300 translated sequences compared). FcRI, FcRII (CD32),
and FcRIII (CD16) show considerable homology to each other
in the first two Ig-like domains, and this homology is con-
served in rodents (30). The homology between gp42 and FcRI,
however, began at the third extracellular domain ofFcRI and
extended through the transmembrane and cytoplasmic do-
mains. An additional homology (GlyGluProLeuAla) was found
between amino acids 157-161 of gp42 and 117-121 of FcRI.
This is within the second 19-like domain of FcRI, but the
homology is not preserved in FcRII or FcRIII. The limited
homologies between gp42 and FcRI may suggest a phy-
logenetic relationship between these two molecules, but gp42
appears to represent a molecule that has not previously been
described in any species.
The plot of hydrophilicity for gp42 demonstrates the ini-
tial hydrophobic signal sequence and an additional hydrophobic
region of -16 amino acids at the COOH terminus (Fig. 3).
The latter region lacks the length and composition of a trans-
membrane domain, and it is not followed by a cytoplasmic
domain. Instead, a hydrophobic COOH terminus of 15-20
amino acids is one feature of glycoproteins that are attached
to the cell surface by a GPI anchor (14, 15), suggesting this
mechanism for attachment of gp42 to the cell membrane.
PI-PLC Releases gp42from the Surface ofRNK16 Cells and
from CHO Cells Transformed with the cDNA for gp42 but not
from rIL2-activated NK Cells. The gp42 molecule was first
identified on the rat leukemia cell line RNK-16, which has
features of NK cells (13, 31). Treatment of RNK-16 cells with
PI-PLC reduced the level ofgp42 on the cell surface by -80%
(Fig. 4 A), with no effect on the expression of transmem-
brane class I MHC molecules (not shown) . Thus, most, if
Figure 4.
￿
Effect ofPI-PLC on the surface expression ofgp42 on RNK-16 cells (A), CHO cells transformed with gp42 cDNA (B), and rIIr2-activated
NK cells (C). (Dotted line) Background staining (isotype-matched fluorescein-conjugated mAb to the mouse antigen NK-1.1). (Light line) Staining of
untreated cells with fluorescein-conjugated mAb to gp42 (3G7). (Dark line) Staining with the same anti-gp42 mAb after treatment with PI-PLC (0.5
U/ml for 1 h at 37°C).not all, native gp42 onRNK16 cells is attached to the cell
membrane by aGPI anchor. PI-PLC also completely released
gp42 from the surface ofCHO cells that had been trans-
fected with gp42cDNA (Fig . 4 B) . Treatment ofrIL2-acti-
vated NK cells with PI-PLC, however, did not release gp42
from the cell surface, even with higher concentrations ofen-
zyme (up to 2 U/ml), as detected either by staining of the
cells with fluorescein-conjugated antibody (Fig. 4 C) or by
release of radiolabeled gp42, isolated by affinity chromatog-
raphy with antibody 3137 (not shown) . This resistance to
PI-PLC, however, was not unique to gp42 ; OX-45 is a GPI-
anchored rat leukocyte antigen (18) that was largely released
from fresh spleen cells by PI-PLC but that, when expressed
on rIL2-activated NK cells, was either not affected by Pl-
PLC or (in two of four experiments) was reduced only slightly
(not shown) . Thus, either gp42 and the OX-45 antigen are
both expressed on rIL2-activated NK cells in a form that
is resistant to PI-PLC, or conditions on the surface of rIL2-
activated NK cells do not permit the activity of PI-PLC .
Studies by Presky et al ., have demonstrated that GPI-
anchored proteins on T lymphocytes become resistant to Pl-
PLC after activation by Con A, anti-CD3, or a combination
of calcium ionophore and PMA (32) . Our findings are con-
sistent with a similar effect, in response to rIL2, on GPI-
anchored proteins expressed by NK cells. Alternatively, rIL2
might stimulate the expression of a transmembrane form of
gp42 by spleen cells, replacing the GPI-anchored form . To
examine this point further, we first sequenced the 3' end of
the open-reading frame from two additional cDNA clones
for gp42 . Both were identical to clones 1 and 2 . Thus, four
independently derived clones from rIL2-activated NK cells
Figure 5 .
￿
SDS-PAGE analysis
of 1251-labeled gp42 immunopre-
cipitated from rIL2-activated NK
cells (A) or from RNK-16 cells
(B) . This gel shows a size differ-
ence of 40.5 kD, the maximum
difference that was observed on
four analyses .
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predict a GPI-anchored protein . Second, we used the PCR
to amplify gp42 cDNA from rIL2-activatedNK cells, using
primers from the 5'-translated and the 3'-untranslated ends
of ourcDNA . A single band was obtained which, when iso-
lated and sequenced, encoded the GPI-anchoring terminus
obtained from the Xgt11 clones (not shown) . Thus, either
a message for a transmembrane form of gp42 is not present
in these cells or the message is not homologous at its termini
to the message for GPI-anchored protein. Finally, weimmu-
noprecipitated surface-labeled gp42 from both rIL2-activated
NK cells and from RNK-16 cells and analyzed the degly-
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Figure 6 . mAbs to gp42 stimulate increases in InsPs (A,B) and in
[Ca2']i in RNK-16 cells. (A) Total InsPs after stimulation with either of
two anti-gp42 mAb (3137 or 6D8), alone or with a second-step goat an-
tiserum to mouse Ig (GaM) . [3H]Inositol-labeled RNK-16 cells were in-
cubated for 6 min with medium alone, with GctM alone, with anti-gp42
mAb alone, or with anti-gp42 followed 3 min later by GoiM . The data
represent the mean and range of duplicate samples. (B) Levels of InsP3,
InSP2, and InsPi, resolved by anion-exchange chromatography in RNK-
16 cells after stimulation by 6D8 alone (closed circles), compared withmedium
alone (open circles) . (C) [Ca2']i in RNK-16 cells, assessed by the Ca2 '-
sensitive fluor Indo-1, in response to anti-gp42 (mAb 6D8) alone and with
subsequent cross-linking by the addition of GofM . [Ca2' ]i, calculated as
described (20), was 185nM in unstimulated cells and rose to 530nM after
the addition of 6D8 alone and to 660nM after crosslinking with GotM .cosylated protein by SDS-PAGE. A single band of -28 kD
was isolated from both. Analysis of four different gels indi-
cated that the bands were either ofidentical size (not shown)
or that gp42 from rIL2-activated NK cells was only slightly
(<0.5 kD) larger than gp42 from RNK-16 cells (Fig. 5). It
is unlikely that this difference in size is sufficient to reflect
the addition of a transmembrane region, especiallyif the mol-
ecule had any cytoplasmic domain. Although a small differ-
ence in size was seen in some gels, this may reflect modification
ofthe GPI anchor, e.g., by acylation, which is associated with
resistanceto PI-PILC by GPI-anchored decay-accelerating factor
(DAF) (33).
Perturbation ofgp42 Causes an Increase in Phosphoinositides
and in [Ca2+J; in RNK16 Leukemia Cells but not in rIL2-
activatedNK Cells. Antibodies to certain GPI-anchored pro-
teins on lymphocytes stimulate the production of soluble InsPs,
and a consequent rise in [Ca2 +];, when the proteins are
cross-linked on the cell surface (34-36) . To examine the effect
of gp42 mAb on the generation of InsPs, RNK-16 cells were
incubated with [3H]inositol and then exposed to anti-gp42.
Alone, the mAb stimulated an -50% increase in total [3H]
InsPs (Fig. 6 A), and a two- to threefold increase in [3H]ino-
sitol trisphosphate (InsP3, Fig. 6 B). The rise in total InsPs was
augmented when anti-gp42 was cross-linked by a second-step
antiserum to mouse Ig (Fig. 6 A). Consistent with the ability
of InSP3 to mobilize intracellular Ca2 +, anti-gp42 mAb
alone stimulated a substantial rise in [Ca2+]; that was fur-
ther augmented by cross-linking (Fig. 6 C).
RNK-16 is cytotoxic to tumors that are killed by fresh rat
NK cells, and we have previously shown that RNK-16 cells
respond to susceptible targets by generating a rise in InsPs
(20). In our previous studies, a rise in InsPs was also gener-
ated by cross-linking anti-CD2 mAb (OX-34) on the surface
of RNK-16 cells (20). Anti-CD2 alone did not stimulate a
rise in InsPs, but it blocked the response of RNK-16 cells
to target cells, as assessed both by cytotoxicity and by changes
in InsPs (20) . Although cross-linking anti-gp42 also gener-
ated a rise in InsPs and in [Ca2 +]; within RNK-16 cells,
soluble anti-gp42 alone did not block the response of RNK-
16 cells to targets as assessed either by cytotoxicity (13) or
by changes in InsPs (not shown). Also, despite the abilities
of gp42 and CD2 to trigger increases in [Ca2 +]; and in InsPs
within RNK-16 cells, these responses could not be elicited
in rIL2-activated NK cells by cross-linking either anti-gp42
or anti-CD2 (not shown) .
Discussion
We have cloned the cDNA for rat gp42, a cell surface gly-
coprotein that is selectively induced on NK cells in response
to rIL2, and we have expressed the gene in CHO cells. Nei-
ther the nucleotide nor the amino acid sequence of gp42
demonstrates significant homology to other known proteins.
Several properties of the gp42 molecule are of interest.
First, the deduced amino acid sequence predicts a mole-
cule that is attached to the cell membrane by a GPI anchor.
In accord with this, treatment with PI-PLC markedly reduced
the expression of gp42 on RNK-16 cells, which constitu-
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tively express gp42, or on CHO cellsthat were transformed
with the cDNA for gp42. In contrast, treatment of rIL2-ac-
tivated NK cells with PI-PLC had no effect on the expres-
sion of gp42. Thus, either gp42 is expressed in a different
manner on rIL2-activated NK cells, or conditions on these
cells do not permit the activity of PI-PLC. With regard to
the first possibility, there are several surface molecules that
can be expressed either as GPI-anchored or as transmembrane
structures. An exampleis the immunoglobulin receptor, CD16,
which is GPI-anchored on polymorphonuclear cells but ex-
pressed as a transmembrane glycoprotein on NK cells (37, 38).
Thus, it is possible that gp42 might be expressed on rIL
2-activated NK cells as a transmembrane protein. Our studies,
however, argue against this. First, our cDNA clones were
prepared from mRNA that was obtained from rIL2-acti-
vated NK cells, and four independently derived clones lack
an apparent transmembrane domain. Second, Northern blot
analysis of rIL2-activated NK cells with gp42 could detect
only a single message (Fig. 1), making it unlikely that these
cells express more than one form of gp42. Third, a single
cDNA species was obtained by PCR from mRNA prepared
from rIL2-activated NK cells. This argues against IL-2-in-
duced expression ofa transmembrane form that is highly ho-
mologous to the GPI form, as is the case for different forms
of CD16 (38). Fourth, immunoprecipitation of surface-labeled
gp42 from rIL2-activated NK cells revealed a single struc-
ture that was nearly identical in size to gp42 on RNK-16
cells. Finally, PI-PLC treatment was relatively ineffective in
cleaving from rIL2-activated NK cells not only gp42 but
also the antigen OX-45, which is expressed on freshly ob-
tained cells as a GPI-anchored protein (18). In all, these findings
suggest that gp42 on rIL2-activated NK cells is attached by
a GPI anchor, as it is on RNK-16 cells, but it is not readily
cleaved by PI-PLC. To further exclude the alternate possi-
bility that gp42 could exist as a transmembrane protein, we
have performed Southern blot analysis of rat genomic DNA
using gp42 cDNA. This identifies an EcoRl fragment of -13
kb. Partial mapping and sequencing ofa genomic clone confirm
that there is a 13-kb EcoRI fragment that encodes a single
gene for GPI-anchored gp42, including all but the 5'-untrans-
lated region and the start ofthe signal sequence (unpublished
studies). There is weaker and more variable hybridization to
fragments of -8 kb and -3 kb, so it is possible that there
are additional genes present with at least partial homology
to gp42.
gp42 was initially identified on the rat leukemia cell line
RNK-16. This cell line has features of NK cells (30), but
gp42 is not expressed in detectable amounts on freshly pre-
pared rat leukocytes, including NK cells (13). Instead it is
uniquely induced on NK cells in response to 1172 (13). Fresh
NK cells express the p70 component of the IL2 receptor at
much higher levels than other lymphocytes, and they may
thus respond more promptly to stimulation by 11,2 (4). How-
ever, gp42 is not detectable on lymphocytes other than NK
cellseven after6 d of culture in IL2 (13). The unique expres-
sion of gp42 on rIL2-activated NK cells, therefore, is not
simply the consequence of a more readyresponse, but rather
a lineage-specific response.The selective expression of gp42 suggests a possible role
for this molecule in regulating responses that are unique to
rIL2-activated NK cells. The physiologic function of gp42,
however, has not been determined. The study of other GPI-
linked surface proteins on mammalian cellsindicates that cer-
tain ofthese, such as LFA-3 and N-CAM, are adhesion mole-
cules (39-41). Others, including alkaline phosphatase (42),
acetylcholinesterase (43), and 5'-nucleotidase (44) have enzy-
matic activity. Of particular relevance to gp42 may be the
demonstration that T lymphocytes can be activated when cer-
tain GPI-anchored proteins are cross-linked in the presence
of PMA. These include certain Ly-6 isoforms (45),Thy-1(46),
DAF (47), and Qa-2 (48), all of which are expressed on T
cells as GPI-anchored proteins (49-53). The T cell prolifera-
tive responses to antiThy-1 and to anti-1y-6 have been studied
in greatest detail. Both responses are dependent on the
expression of the TCR/CD3 complex; T cell lines lacking
the TCR/CD3 complex are not activated, and the response
is restored when expression of the complex is restored (54,
55). For Ly-6, the opposite has also been demonstrated;
inhibition of Ly-6 expression by antisense oligonucleotides
prevents activation of T cells through the TCR (56). Thus,
GPI-anchored proteins may play a vital role in lymphocyte
activation. The activation of T cells through the TCR/CD3
complex involves the generation of InsPs with a consequent
rise in [Ca2 +]; (57). Cross-linking of either Thy-1 or Ly-6
also stimulates a rise in [Ca211,, suggesting that this re-
sponse might be involved in lymphocyte activation through
Thy-1 or Ly-6 (34, 35).
We found that gp42 stimulates the generation of InsPs and
a rise in [Ca2 +]; in RNK-16 leukemia cells. Because this is
a property of other GPI-linked molecules that activate lym-
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